Shares of Nuwellis Inc (NASDAQ:NUWE) are skyrocketing Wednesday morning after the medical technology company announced it secured a key U.S. patent for its blood filtering technology.
What To Know: The U.S. Patent and Trademark Office officially granted the patent on Tuesday, Nuwellis announced after the market closed. The new patent, U.S. Patent No. 12,357,734, protects a method for improving the accuracy of fluid balance calculations in Continuous Renal Replacement Therapy. It addresses a known flaw in current systems that use weight-based measurements and assume a standard fluid density.
